DWI - histology: a possible means of determining degree of liver fibrosis?
Niklas Verloh(University Hospital Regensburg), Philipp Wiggermann(Klinikum Braunschweig), Philipp Renner(Robert Bosch Hospital), Michael Haimerl(University Hospital Regensburg), Claudia Fellner(University Hospital Regensburg), Florian Zeman(University Hospital Regensburg), Kirsten Utpatel(University of Regensburg), Timo Seyfried(University Hospital Regensburg), Marc H. Dahlke(Robert Bosch Hospital), Christian Stroszczynski(University Hospital Carl Gustav Carus), Martina Müller(University Hospital Regensburg), Matthias Evert(University of Regensburg)
Cited by 4
Related Papers
Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial
|The Lancet Oncology|2009|960
Lymphocyte apoptosis induced by CD95 (APO–1/Fas) ligand–expressing tumor cells — A mechanism of immune evasion?
|Nature Medicine|1996|906
p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs
|The Journal of Experimental Medicine|1998|897
Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53.
|Journal of Clinical Investigation|1997|771
Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs
|Frontiers in Immunology|2019|696